静脈内輸液ポンプの市場規模、シェア、動向分析レポート：製品別、適応疾患別、地域別、セグメント予測、2025年～2030年

静脈内輸液ポンプ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、静脈内輸液ポンプの世界市場規模は2030年までに99億8,000万米ドルに達し、予測期間中にCAGR8.5％で拡大すると予測されています。

がん、糖尿病、心血管疾患、呼吸器疾患などの慢性疾患の有病率の増加により、正確な投薬や治療管理が必要となり、輸液ポンプの需要を牽引しています。

世界の高齢化は、特に外来患者や在宅介護の現場での輸液ポンプの採用をさらに加速しており、複雑な投薬レジメンを管理する高齢患者の安全で正確なドラッグデリバリーを促進しています。世界保健機関（WHO）の報告によると、2024年の出生時平均余命は73.3歳で、1995年以来8.4歳延びています。さらに、60歳以上の世界人口は2023年の11億人から2030年には14億人に達すると予測されており、このような技術の必要性が高まっていることを浮き彫りにしています。

輸液ポンプ機能の技術的進歩は、市場の需要を大きく後押ししています。ワイヤレス接続、EHR統合、自動プログラミングを特徴とするスマート輸液ポンプは、投薬ミスを最小限に抑え、ワークフローを合理化することで、患者の安全性と業務効率を高めます。

静脈内輸液ポンプレポートハイライト：

• 定量注入ポンプは、2024年に製品セグメントで最大の市場シェアを占めました。大量の輸液を正確に行うその有効性は、がんや糖尿病などの慢性疾患の管理や外科手術に不可欠です。
• インスリン注入ポンプは、予測期間中に9.0％を超える最も速いCAGRで成長すると予測されています。主に高齢化、不健康なライフスタイル、肥満率の増加による糖尿病有病率の世界の上昇が、インスリンポンプ需要を牽引しています。
• 小児科/新生児科は、2024年の総売上シェアの25.0％以上を占め、疾患適応セグメントを支配しています。
• 化学療法分野は、がん患者数の増加とがん治療薬の急速な開発により、予測期間中に最も速いCAGRで成長すると予測されています。
• 北米は、高度な医療インフラ、慢性疾患の増加、技術の進歩により、静脈内輸液ポンプ市場を独占しています。
• 2024年5月、Moog Inc.はCURLIN 8000 Ambulatory Infusion SystemのFDA 510（k）認可を取得しました。この新しいマルチセラピープラットフォームは、在宅輸液環境での使いやすさと安全性を高めるために設計されました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 静脈内輸液ポンプ市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 静脈内輸液ポンプ市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析
• 静脈内輸液ポンプ市場：パイプライン分析

第4章 静脈内輸液ポンプ市場：製品推定・動向分析

• 製品セグメントダッシュボード
• 静脈内輸液ポンプ市場：製品変動分析
• 世界の静脈内輸液ポンプの市場規模と動向分析（製品別、2018年～2030年）
• 容積式輸液ポンプ
• シリンジ輸液ポンプ
• インスリン注入ポンプ
• 経腸輸液ポンプ
• 携帯型輸液ポンプ
• 患者自己管理鎮痛輸液ポンプ
• 埋め込み型輸液ポンプ
• その他

第5章 静脈内輸液ポンプ市場：疾患適応症推定・動向分析

• 疾患適応セグメントダッシュボード
• 静脈内輸液ポンプ市場：疾患適応症変動分析
• 世界の静脈内輸液ポンプの市場規模と動向分析（疾患適応症別、2018年～2030年）
• 化学療法
• 糖尿病
• 消化器内科
• 鎮痛/疼痛管理
• 小児科・新生児科
• 血液学
• その他

第6章 静脈内輸液ポンプ市場：地域推定・動向分析

• 地域市場ダッシュボード
• 地域別市場シェア分析、2024年・2030年
• 静脈輸液ポンプ市場：地域別、主なポイント
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 最近の動向と影響分析：主要市場参入企業別
• 企業/競合の分類
• ベンダー情勢
  • 主要企業のヒートマップ分析、2024年
• 企業プロファイル
  • Baxter
  • B. Braun Medical Inc.
  • Medtronic
  • Micrel Medical Devices SA
  • Boston Scientific Corporation
  • Cardinal Health
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • F. Hoffmann-La Roche Ltd
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Moog Inc.
  • IRadimed Corporation

List of Tables

• Table 1 List of abbreviations
• Table 2 Global intravenous infusion pumps market, by region, 2018 - 2030 (USD Million)
• Table 3 Global intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 4 Global intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 5 North America intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
• Table 6 North America intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 7 North America intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 8 U.S. intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 9 U.S. intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 10 Canada intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 11 Canada intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 12 Mexico intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 13 Mexico surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
• Table 14 Europe intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
• Table 15 Europe intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 16 Europe intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 17 UK intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 18 UK intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 19 Germany intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 20 Germany intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 21 France intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 22 France intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 23 Italy intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 24 Italy intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 25 Spain intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 26 Spain intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 27 Denmark intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 28 Denmark intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 29 Sweden intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 30 Sweden intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 31 Norway intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 32 Norway intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
• Table 34 Asia Pacific intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 35 Asia Pacific intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 36 China intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 37 China intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 38 Japan intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 39 Japan intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 40 India intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 41 India intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 42 Australia intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 43 Australia intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 44 South Korea intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 45 South Korea intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 46 Thailand intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 47 Thailand intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 48 Latin America intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
• Table 49 Latin America intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 50 Latin America laparoscopic ablation market, by disease indication, 2018 - 2030 (USD Million)
• Table 51 Latin America percutaneous ablation market, by disease indication, 2018 - 2030 (USD Million)
• Table 52 Latin America intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 53 Brazil intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 54 Brazil surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
• Table 55 Argentina intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 56 Argentina surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
• Table 57 MEA intravenous infusion pumps market, by region, 2018 - 2030 (USD Million)
• Table 58 MEA intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 59 MEA intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 60 South Africa intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 61 South Africa intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 62 Saudi Arabia intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 63 Saudi Arabia intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 64 UAE intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 65 UAE intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
• Table 66 Kuwait intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
• Table 67 Kuwait intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Intravenous infusion pumps market: market outlook
• Fig. 10 Intravenous infusion pumps competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 Intravenous infusion pumps market driver impact
• Fig. 16 Intravenous infusion pumps market restraint impact
• Fig. 17 Intravenous infusion pumps market strategic initiatives analysis
• Fig. 18 Intravenous infusion pumps market: Product movement analysis
• Fig. 19 Intravenous infusion pumps market: Product outlook and key takeaways
• Fig. 20 Volumetric infusion pumps estimates and forecast, 2018 - 2030
• Fig. 21 Syringe infusion pumps estimates and forecast, 2018 - 2030
• Fig. 22 Insulin infusion pumps estimates and forecast, 2018 - 2030
• Fig. 23 Enteral infusion pumps estimates and forecast, 2018 - 2030
• Fig. 24 Ambulatory infusion pumps estimates and forecast, 2018 - 2030
• Fig. 25 Patient-controlled analgesia infusion pumps estimates and forecast, 2018 - 2030
• Fig. 26 Implantable infusion pumps estimates and forecast, 2018 - 2030
• Fig. 27 Others estimates and forecast, 2018 - 2030
• Fig. 28 Intravenous infusion pumps market: Disease indication movement analysis
• Fig. 29 Intravenous infusion pumps market: Disease indication outlook and key takeaways
• Fig. 30 Chemotherapy estimates and forecast, 2018 - 2030
• Fig. 31 Diabetes estimates and forecast, 2018 - 2030
• Fig. 32 Gastroenterology estimates and forecast, 2018 - 2030
• Fig. 33 Analgesia/pain management estimates and forecast, 2018 - 2030
• Fig. 34 Pediatrics/neonatology estimates and forecast, 2018 - 2030
• Fig. 35 Hematology estimates and forecast, 2018 - 2030
• Fig. 36 Others estimates and forecast, 2018 - 2030
• Fig. 37 Global intravenous infusion pumps market: Regional movement analysis
• Fig. 38 Global intravenous infusion pumps market: Regional outlook and key takeaways
• Fig. 39 North America market estimates and forecasts, 2018 - 2030
• Fig. 40 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 41 Canada market estimates and forecasts, 2018 - 2030
• Fig. 42 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 43 Europe market estimates and forecasts, 2018 - 2030
• Fig. 44 UK market estimates and forecasts, 2018 - 2030
• Fig. 45 Germany market estimates and forecasts, 2018 - 2030
• Fig. 46 France market estimates and forecasts, 2018 - 2030
• Fig. 47 Italy market estimates and forecasts, 2018 - 2030
• Fig. 48 Spain market estimates and forecasts, 2018 - 2030
• Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 51 Norway market estimates and forecasts, 2018 - 2030
• Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 53 China market estimates and forecasts, 2018 - 2030
• Fig. 54 Japan market estimates and forecasts, 2018 - 2030
• Fig. 55 India market estimates and forecasts, 2018 - 2030
• Fig. 56 Australia market estimates and forecasts, 2018 - 2030
• Fig. 57 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 58 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 61 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 62 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 65 UAE market estimates and forecasts, 2018 - 2030
• Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030

Intravenous Infusion Pumps Market Growth & Trends:

The global intravenous infusion pumps market size is anticipated to reach USD 9.98 billion by 2030 and is anticipated to expand at a CAGR of 8.5% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic conditions, including cancer, diabetes, cardiovascular, and respiratory diseases, necessitates precise medication and therapy administration, thereby driving the demand for infusion pumps.

The global aging population further amplifies the adoption of infusion pumps, particularly in outpatient and home care settings, where they facilitate safe and accurate drug delivery for elderly patients managing complex medication regimens. The World Health Organization reported that life expectancy at birth increased to 73.3 years in 2024, a rise of 8.4 years since 1995. Moreover, the global population aged 60 and older is projected to reach 1.4 billion by 2030, up from 1.1 billion in 2023, highlighting the growing need for such technologies.

Technological advancements in infusion pump capabilities significantly bolster market demand. Smart infusion pumps, featuring wireless connectivity, EHR integration, and automated programming, enhance patient safety and operational efficiency by minimizing medication errors and streamlining workflows

Intravenous Infusion Pumps Report Highlights:

• Volumetric infusion pumps held the largest market share in the product segment in 2024. Their efficacy in delivering large volumes precisely is vital in managing chronic diseases such as cancer and diabetes and in surgical procedures.
• Insulin infusion pumps are projected to grow at the fastest CAGR of over 9.0% over the forecast period. The global rise in diabetes prevalence, primarily due to aging populations, unhealthy lifestyles, and increasing obesity rates, has driven insulin pump demand.
• Pediatrics/neonatology dominated the disease indication segment with over 25.0% of the total revenue share in 2024.
• The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period, driven by the rising number of cancer cases and rapid development in oncological drugs.
• North America dominated the intravenous infusion pumps market due to its advanced medical infrastructure, increasing chronic disease prevalence, and technological advancements.
• In May 2024, Moog Inc. received FDA 510(k) clearance for its CURLIN 8000 Ambulatory Infusion System. This new multi-therapy platform was designed for enhanced usability and safety in home infusion settings.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Disease Indication
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Disease indication outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Intravenous Infusion Pumps Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Intravenous Infusion Pumps Market: Pipeline Analysis

Chapter 4. Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Intravenous Infusion Pumps Market: Product Movement Analysis
• 4.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Volumetric Infusion Pumps
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Syringe Infusion Pumps
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Insulin Infusion Pumps
  • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Enteral Infusion Pumps
  • 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Ambulatory Infusion Pumps
  • 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Patient-Controlled Analgesia Infusion Pumps
  • 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.10. Implantable Infusion Pumps
  • 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.11. Others
  • 4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis

• 5.1. Disease Indication Segment Dashboard
• 5.2. Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
• 5.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
• 5.4. Chemotherapy
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Diabetes
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Gastroenterology
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Analgesia/Pain Management
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Pediatrics/Neonatology
  • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Hematology
  • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.10. Others
  • 5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Dashboard
• 6.2. Regional Market Share Analysis, 2024 & 2030
• 6.3. Intravenous infusion pumps market by Region: Key Takeaways
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework/ reimbursement structure
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework/ reimbursement structure
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.6. Denmark
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.8. Norway
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework/ reimbursement structure
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. China
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework/ reimbursement structure
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. India
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. Australia
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework/ reimbursement structure
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework/ reimbursement structure
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Thailand
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework/ reimbursement structure
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework/ reimbursement structure
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Argentina
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework/ reimbursement structure
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework/ reimbursement structure
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. UAE
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework/ reimbursement structure
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework/ reimbursement structure
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key company heat map analysis, 2024
• 7.4. Company Profiles
  • 7.4.1. Baxter
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. B. Braun Medical Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Medtronic
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Micrel Medical Devices SA
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Boston Scientific Corporation
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Cardinal Health
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Fresenius Kabi AG
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. ICU Medical, Inc.
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. F. Hoffmann-La Roche Ltd
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Tandem Diabetes Care, Inc.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. Terumo Corporation
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Moog Inc.
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. IRadimed Corporation
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives